TNYA
TNYA
NASDAQ · Biotechnology

Tenaya Therapeutics Inc

$0.74
+0.00 (+0.57%)
As of Jun 30, 10:27 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +4,791.1% upside
Low Target $26.32
Average Target $36.15
High Target $48.95
Current Price $0.74
Current
$0.74
Target
$36.15
$26.32 $36.15 avg $48.95
Scenario Analysis
Bear Case
$26.32
3,461.1%
Low target
Base Case
$36.15
+4,791.1%
Avg target
Bull Case
$48.95
+6,522.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.35
-68.5% from high
52-Week Low
$0.53
+38.9% from low
Target vs 52W High
$36.15
+1,438.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%